PLK1 and neoplasm: ECT2 is a biomarker that can be used for diagnosis and prognostic prediction in HCC, and its overexpression could promote lactic acid production through the ECT2/PLK1/PTEN pathway, enhance tumor-associated macrophage infiltration, and suppress immune cell function [33].